Citi raised the firm’s price target on Glaukos to $107 from $101 and keeps a Buy rating on the shares following the Q4 report. For iStent Infinite, demand remains strong, having advanced market initiatives, the analyst tells investors in a research note. The firm suspects the company’s 2024 guidance is conservative.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GKOS:
- Glaukos Quarterly Summary: Performance Insights and Disclosures
- GKOS Earnings this Week: How Will it Perform?
- Glaukos backs FY24 revenue view $350M-$360M, consensus $352.71M
- Glaukos raises FY23 revenue view to $313M from $307M-$310M, consensus $309.02M
- Glaukos reports preliminary Q4 revenue $81M, consensus $76.66M
